Koen Kas is a healthcare thought leader, driven by the aim to make healthcare personalised, predictive, and ultimately preventive. He recently published his vision in a book (Nooit meer ziek, “Sick no more”), describing how we will evolve to such future.
As founding CEO of InBioVeritas, Founding Partner at Advance.Healthcare and Partner at Healthstartup, he ideates and facilitates innovative disruptions in healthcare, organises hackatons, and creates novel digital health startups. He serves on the Scientific Advisory Board of a large number of life sciences companies & investors.
He’s preparing the launch of a new medium, Healthskouts, helping corporates to unlock unknowns, delivering delightful, actionable innovation & business development suggestions & insights from the latest research & technology breakthroughs, emerging startups, design ideas and business models from within & outside of healthcare.
Before, he spent 15 years in executive positions at 4 leading biotech companies. As CSO Oncology of Thrombogenics he spun out Oncurious, which recently obtained its IND to start clinical trials with a pediatric brain tumour drug. Koen was earlier founding CEO & CSO of Pronota, a company committed to better diagnosis and personalized medicine in the areas of ovarian cancer, preeclampsia, cardio-renal failure & sepsis. He was, prior to that Director drug discovery at Galapagos, one of the leading European life-sciences companies. Previously, he set up and directed the Cancer drug discovery program at Tibotec (now Johnson & Johnson). Koen is professor Molecular Oncology at the University of Ghent, Belgium, and chairs the scientific committee of the European Cancer Prevention Organisation.